• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Essential Medicine Utilization and Situation in Selected Ten Developing Countries: A Compendious Audit.十个选定发展中国家的基本药物使用情况与现状:简要审计
J Int Soc Prev Community Dent. 2017 Jul-Aug;7(4):147-160. doi: 10.4103/jispcd.JISPCD_224_17. Epub 2017 Jul 31.
2
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.高收入、中等收入和低收入国家的糖尿病基本药物的可及性和可负担性:一项前瞻性流行病学研究。
Lancet Diabetes Endocrinol. 2018 Oct;6(10):798-808. doi: 10.1016/S2213-8587(18)30233-X. Epub 2018 Aug 28.
3
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.发展中国家心血管疾病和高血压药物的可及性:基本药物清单、价格、可获得性及可负担性分析
J Am Heart Assoc. 2020 May 5;9(9):e015302. doi: 10.1161/JAHA.119.015302. Epub 2020 Apr 25.
4
Mapping actions to improve access to medicines for mental disorders in low and middle income countries.制定行动方案,以改善中低收入国家精神障碍药物的可及性。
Epidemiol Psychiatr Sci. 2017 Oct;26(5):481-490. doi: 10.1017/S2045796016001165. Epub 2017 Jan 9.
5
Rational use of medicines - Indian perspective!药品的合理使用——印度视角!
Int J Risk Saf Med. 2015;27 Suppl 1:S47-8. doi: 10.3233/JRS-150684.
6
Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.埃塞俄比亚西部儿童基本药物的可及性与可负担性:对获取情况的影响
BMC Pediatr. 2016 Mar 15;16:40. doi: 10.1186/s12887-016-0572-3.
7
Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities.在低收入和中等收入国家,将零售药店作为公共部门客户基本药物的来源:对关键考虑因素、挑战和机遇的范围界定审查
J Pharm Policy Pract. 2023 May 2;16(1):60. doi: 10.1186/s40545-023-00557-w.
8
An Analysis of Accessibility of Representative Psychotropic Medicine From the World Health Organization Model List of Essential Medicines in Developing Countries With Different Income Levels.不同收入水平发展中国家可获取世界卫生组织基本药物示范目录中代表性精神药物情况分析
Value Health. 2023 Apr;26(4):528-535. doi: 10.1016/j.jval.2022.11.009. Epub 2022 Nov 26.
9
Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.对世界卫生组织关于治疗非传染性疾病基本药物的可及性和可负担性目标的基线评估。
PLoS One. 2017 Feb 7;12(2):e0171284. doi: 10.1371/journal.pone.0171284. eCollection 2017.
10
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries.低收入和中等收入国家心血管疾病药物的可及性
Circulation. 2016 May 24;133(21):2076-85. doi: 10.1161/CIRCULATIONAHA.115.008722.

引用本文的文献

1
A Systematic Review on Evaluation of WHO Core Prescribing Indicators Across Healthcare Facilities in Low Resource Asian Setting: A Case of Nepal.低资源亚洲环境下医疗机构中世卫组织核心处方指标评估的系统评价:以尼泊尔为例
Inquiry. 2025 Jan-Dec;62:469580251347136. doi: 10.1177/00469580251347136. Epub 2025 Jun 14.
2
Public sector pharmaceutical distribution system and its challenges: a case of a central Ethiopian Pharmaceuticals Supply Service and selected branches.公共部门药品配送系统及其挑战:以埃塞俄比亚中部药品供应服务局及部分分支机构为例
BMC Health Serv Res. 2025 Feb 19;25(1):278. doi: 10.1186/s12913-025-12404-6.
3
Short- and long-term impacts of the National Essential Medicines Policy on drug availability, price, and usage in a deprived rural county in southwestern China: an interrupted time series analysis across 8 years.中国西南贫困农村地区国家基本药物政策对药品供应、价格和使用的短期和长期影响:8 年的中断时间序列分析。
Front Public Health. 2024 Aug 29;12:1355239. doi: 10.3389/fpubh.2024.1355239. eCollection 2024.
4
Use of drugs not listed in the National List of Essential Medicines: Findings from a prescription analysis by the Indian Council of Medical Research-Rational Use of Medicines Centres Network in tertiary care hospitals across India.未列入国家基本药物目录的药品使用情况:印度医学研究理事会-合理用药中心网络在印度三级保健医院进行的处方分析结果。
Indian J Pharmacol. 2022 Nov-Dec;54(6):407-416. doi: 10.4103/ijp.ijp_878_21.
5
National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis.国家对世界卫生组织基本药物标准清单的适应和实施:定性证据综合分析。
PLoS Med. 2022 Mar 11;19(3):e1003944. doi: 10.1371/journal.pmed.1003944. eCollection 2022 Mar.
6
Neuropathic pain in Mali: The current situation, comprehensive hypothesis, which therapeutic strategy for Africa?马里的神经性疼痛:现状、综合假说及非洲的治疗策略是什么?
eNeurologicalSci. 2021 Jan 9;22:100312. doi: 10.1016/j.ensci.2021.100312. eCollection 2021 Mar.
7
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.微生物耐药动态:对抗菌药物耐药性所构成的全球公共卫生威胁的概述以及最佳应对方法。
Front Public Health. 2020 Nov 4;8:535668. doi: 10.3389/fpubh.2020.535668. eCollection 2020.
8
Hits and misses of Bangladesh National Health Policy 2011.《2011年孟加拉国国家卫生政策》的成败之处
J Pharm Bioallied Sci. 2020 Apr-Jun;12(2):83-93. doi: 10.4103/jpbs.JPBS_236_19. Epub 2020 Apr 10.
9
Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal.尼泊尔中部三级医疗区医院门诊部处方模式及处方错误评估
J Pharm Policy Pract. 2019 Jul 10;12:16. doi: 10.1186/s40545-019-0177-y. eCollection 2019.

本文引用的文献

1
Monitoring medicines use to support national medicines policy development and implementation in the Asia Pacific region.监测药品使用情况以支持亚太地区国家药品政策的制定与实施。
WHO South East Asia J Public Health. 2013 Apr-Jun;2(2):113-117. doi: 10.4103/2224-3151.122946.
2
Pharmacy Practice in Nepal.尼泊尔的药学实践。
Can J Hosp Pharm. 2016 Nov-Dec;69(6):493-500. doi: 10.4212/cjhp.v69i6.1614. Epub 2016 Dec 23.
3
Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members.南非基本药物的选择——对国家基本药物清单委员会成员的深入访谈分析
BMC Health Serv Res. 2017 Jan 7;17(1):17. doi: 10.1186/s12913-016-1946-9.
4
Quantitative evaluation of essential medicines lists: the South African case study.基本药物清单的定量评估:南非案例研究
BMC Health Serv Res. 2016 Dec 12;16(1):687. doi: 10.1186/s12913-016-1937-x.
5
Assessment of drug use patterns in terms of the WHO patient-care and facility indicators at four hospitals in Southern Ethiopia: a cross-sectional study.根据世界卫生组织患者护理和机构指标对埃塞俄比亚南部四家医院的药物使用模式进行评估:一项横断面研究。
BMC Health Serv Res. 2016 Nov 10;16(1):643. doi: 10.1186/s12913-016-1882-8.
6
Essential Medicines in National Constitutions: Progress Since 2008.国家宪法中的基本药物:2008年以来的进展
Health Hum Rights. 2016 Jun;18(1):141-156.
7
Assessment of medicines use pattern using World Health Organization's Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia.在埃塞俄比亚东部部分医疗机构中,使用世界卫生组织的处方、患者护理和医疗机构指标评估药品使用模式。
BMC Health Serv Res. 2016 Apr 23;16:144. doi: 10.1186/s12913-016-1414-6.
8
Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.埃塞俄比亚西部儿童基本药物的可及性与可负担性:对获取情况的影响
BMC Pediatr. 2016 Mar 15;16:40. doi: 10.1186/s12887-016-0572-3.
9
Availability of medicines in public sector health facilities of two North Indian States.印度北部两个邦的公共部门卫生机构的药品供应情况。
BMC Pharmacol Toxicol. 2015 Dec 23;16:43. doi: 10.1186/s40360-015-0043-8.
10
Pricing and availability of some essential child specific medicines in Odisha.奥里萨邦一些针对儿童的基本药物的定价和可及性。
Indian J Pharmacol. 2015 Sep-Oct;47(5):496-501. doi: 10.4103/0253-7613.165197.

十个选定发展中国家的基本药物使用情况与现状:简要审计

Essential Medicine Utilization and Situation in Selected Ten Developing Countries: A Compendious Audit.

作者信息

Haque Mainul

机构信息

Unit of Pharmacology, Faculty of Medicine and Defence Health, National Defence University of Malaysia, 57000 Kuala Lumpur, Malaysia.

出版信息

J Int Soc Prev Community Dent. 2017 Jul-Aug;7(4):147-160. doi: 10.4103/jispcd.JISPCD_224_17. Epub 2017 Jul 31.

DOI:10.4103/jispcd.JISPCD_224_17
PMID:28852629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5558247/
Abstract

Medicine improves the quality of life and increases mean age of human beings as it fights against diseases. Accessibility to medicines is the fundamental right of every person. The principle of the essential medicines (EMs) is that a limited number of availability of medicine will promote to a better supply chain and rational prescribing to the rural and remote health centers for any developing countries. Furthermore, it was also expected that this concept will also ensure better procurement policy at lower costs, more in amount, with easier storage. Thereby, EMs will safeguard and improve distribution and dispensing of medicine. Correspondingly, motivational and dedicated training program regarding drug information and adverse drug reactions will boost up access to medicine and health-care. In addition, the selection of medicine from EM is the first step in the direction of the rational use of medicine and progress and ensuring the quality of health care. Thereafter, selection needs to be followed by appropriate use. Everyone should receive the right medicine, in an adequate dose for an adequate duration, with appropriate information and follow-up treatment, and at an affordable cost. The acceptance and implementation of World Health Organization-promoted EM policies in deferent countries have improved quality use of medicine in terms of accessibility and affordability, predominantly in developing countries. The corporations and teamwork among various participants of health care are instantly obligatory to progress equitable access to medicines in low- and middle-income countries.

摘要

医学通过对抗疾病提高了生活质量并延长了人类的平均寿命。药品可及性是每个人的基本权利。基本药物(EMs)原则是,对于任何发展中国家而言,有限数量的药品供应将促进建立更好的供应链,并促使向农村和偏远地区的卫生中心合理开药。此外,人们还期望这一概念还将确保以更低的成本、更多的数量、更易于储存的方式制定更好的采购政策。因此,基本药物将保障并改善药品的分发和配药。相应地,关于药物信息和药物不良反应的激励性和专门培训计划将促进药品可及性和医疗保健。此外,从基本药物中选择药物是朝着合理用药、进步以及确保医疗保健质量方向迈出的第一步。此后,选择之后应进行适当使用。每个人都应获得正确的药物,以适当的剂量服用适当的疗程,并获得适当的信息和后续治疗,且费用要可承受。世界卫生组织推广的基本药物政策在不同国家的接受和实施,在可及性和可承受性方面改善了药品的合理使用,主要是在发展中国家。医疗保健各参与者之间的合作与团队合作对于在低收入和中等收入国家实现公平的药品可及性至关重要。